Type 2 Diabetes (T2DM) Clinical Trials

10 recruiting

Frequently Asked Questions

Common questions about Type 2 Diabetes (T2DM) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 3

A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome

Type 2 Diabetes (T2DM)LipidemiaMetabolic Syndrome (MetS)
NewAmsterdam Pharma300 enrolled20 locationsNCT07219602
Recruiting

The Establishment of Hong Kong Diabetes Steatotic Liver Disease Register

Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 Diabetes (T2DM)
Chinese University of Hong Kong1,000 enrolled1 locationNCT07437157
Recruiting
Not Applicable

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

Obesity, OverweightType 2 Diabetes (T2DM)Obesity (Disorder)
GT Metabolic Solutions, Inc.20 enrolled1 locationNCT07317115
Recruiting
Not Applicable

Glucagon Resistance in Patients With MASLD and T2DM

Type 2 Diabetes (T2DM)Metabolic Associated Fatty Liver Disease
University of Aarhus24 enrolled1 locationNCT07246421
Recruiting

"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Continuous Glucose Monitoring"

Type 2 Diabetes (T2DM)HypoglycemiaType 1 Diabetes (T1D)
Medical University of Warsaw100 enrolled1 locationNCT07286500
Recruiting
Phase 3

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd.477 enrolled4 locationsNCT07064486
Recruiting
Not Applicable

The GRoceries Aimed at Increasing Nutrition Study

Type 2 Diabetes Mellitus (T2DM)Type 2 DiabetesType 2 Diabetes (T2DM)+6 more
University of Pennsylvania216 enrolled1 locationNCT07167004
Recruiting

Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

Type 2 Diabetes (T2DM)Hypercortisolism
Shanghai 6th People's Hospital500 enrolled1 locationNCT07156370
Recruiting
Not Applicable

The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes

Type 2 Diabetes (T2DM)Continuous Glucose Monitoring
Peking University600 enrolled2 locationsNCT07097415
Recruiting
Not Applicable

Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study

Type 2 Diabetes (T2DM)Hypoglycemia (Diabetic)
Ottawa Hospital Research Institute120 enrolled1 locationNCT07094529